Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Guochuang Pharmaceutical is a China-based pharmaceutical company that integrates research, development, production, and sales. The company focuses on therapeutic areas such as urology, cardiovascular diseases, and gastroenterology. Its flagship product, Pule'an, is a widely recognized botanical medicine derived from Pollen Typhae used for treating benign prostatic hyperplasia and chronic prostatitis. In addition to its proprietary botanical products, the company manufactures and distributes a range of chemical drugs, including anti-infectives and treatments for digestive disorders. Guochuang operates manufacturing facilities that comply with GMP standards and maintains a robust sales network across China. The company has historically sought to expand its R&D capabilities in both traditional Chinese medicine and modern chemical synthesis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Guochuang Pharmaceutical.